These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2884031

  • 1. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.
    Ganapathi R, Grabowski D, Schmidt H, Bell D, Melia M.
    Cancer Res; 1987 Jul 01; 47(13):3464-8. PubMed ID: 2884031
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma.
    Gautam SC, Chikkala NF, Lewis I, Grabowski DR, Finke JH, Ganapathi R.
    Anticancer Res; 1992 Jul 01; 12(3):921-5. PubMed ID: 1622150
    [Abstract] [Full Text] [Related]

  • 3. Abnormally banded chromosomal regions in doxorubicin-resistant B16-BL6 murine melanoma cells.
    Slovak ML, Hoeltge GA, Ganapathi R.
    Cancer Res; 1986 Aug 01; 46(8):4171-7. PubMed ID: 3731084
    [Abstract] [Full Text] [Related]

  • 4. Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B16 melanoma sublines of various metastatic properties.
    Irimura T, Nicolson GL.
    Cancer Res; 1984 Feb 01; 44(2):791-8. PubMed ID: 6692378
    [Abstract] [Full Text] [Related]

  • 5. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R, Grabowski D, Sweatman TW, Seshadri R, Israel M.
    Br J Cancer; 1989 Dec 01; 60(6):819-26. PubMed ID: 2605093
    [Abstract] [Full Text] [Related]

  • 6. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL, Wilder PJ, Biswal N.
    Cancer Commun; 1989 Dec 01; 1(3):181-90. PubMed ID: 2576972
    [Abstract] [Full Text] [Related]

  • 7. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, Li LH, Bhuyan BK.
    Cancer Res; 1990 Apr 15; 50(8):2485-92. PubMed ID: 2317831
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL, Inoue T, Van Pelt CS, Cavanaugh PG.
    Cancer Res; 1990 Feb 01; 50(3):515-20. PubMed ID: 2297694
    [Abstract] [Full Text] [Related]

  • 9. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 10. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
    Yang LY, Trujillo JM.
    Cancer Res; 1990 Jun 01; 50(11):3218-25. PubMed ID: 2334917
    [Abstract] [Full Text] [Related]

  • 11. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T, Gonzalez R, Nicolson GL.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA, Thrall BD, Raha G, Meadows GG.
    Nutr Cancer; 1996 Sep 01; 25(1):47-60. PubMed ID: 8837861
    [Abstract] [Full Text] [Related]

  • 13. Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
    Ganapathi R, Schmidt H, Grabowski D, Melia M, Ratliff N.
    Br J Cancer; 1988 Sep 01; 58(3):335-40. PubMed ID: 3179186
    [Abstract] [Full Text] [Related]

  • 14. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW, Alterman AL, Fornabaio DM.
    Invasion Metastasis; 1985 Sep 01; 5(3):125-43. PubMed ID: 3888909
    [Abstract] [Full Text] [Related]

  • 15. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
    Ishiguro T, Nakajima M, Naito M, Muto T, Tsuruo T.
    Cancer Res; 1996 Feb 15; 56(4):875-9. PubMed ID: 8631027
    [Abstract] [Full Text] [Related]

  • 16. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
    Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC, Imai K.
    Oncogene; 1997 Jun 19; 14(24):2971-7. PubMed ID: 9205104
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE, Raffin TA, Brown JM, Newman RA, Etiz BB, Sikic BI.
    Cancer Res; 1986 Apr 19; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [Abstract] [Full Text] [Related]

  • 19. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, Weizman A.
    Oncol Rep; 2006 Jan 19; 15(1):107-12. PubMed ID: 16328041
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 19; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.